EP2056852A4 - Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen - Google Patents

Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen

Info

Publication number
EP2056852A4
EP2056852A4 EP07798210A EP07798210A EP2056852A4 EP 2056852 A4 EP2056852 A4 EP 2056852A4 EP 07798210 A EP07798210 A EP 07798210A EP 07798210 A EP07798210 A EP 07798210A EP 2056852 A4 EP2056852 A4 EP 2056852A4
Authority
EP
European Patent Office
Prior art keywords
bmp
methods
variant compositions
variant
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07798210A
Other languages
English (en)
French (fr)
Other versions
EP2056852A2 (de
Inventor
Bernard Amegadzie
Mark R Cunningham
Haimanti Dorai
Jeffrey Luo
Juliane Mills
Bethany Swencki-Underwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Publication of EP2056852A2 publication Critical patent/EP2056852A2/de
Publication of EP2056852A4 publication Critical patent/EP2056852A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
EP07798210A 2006-07-27 2007-06-07 Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen Withdrawn EP2056852A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82053806P 2006-07-27 2006-07-27
PCT/US2007/070584 WO2008014054A2 (en) 2006-07-27 2007-06-07 Bmp-7 variant compositions, methods and uses

Publications (2)

Publication Number Publication Date
EP2056852A2 EP2056852A2 (de) 2009-05-13
EP2056852A4 true EP2056852A4 (de) 2010-01-13

Family

ID=38982164

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07798210A Withdrawn EP2056852A4 (de) 2006-07-27 2007-06-07 Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen

Country Status (3)

Country Link
EP (1) EP2056852A4 (de)
JP (1) JP2009544325A (de)
WO (1) WO2008014054A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101274930B1 (ko) * 2011-06-03 2013-06-17 전남대학교산학협력단 골 형성 또는 혈관신생 촉진용 펩타이드 bfp 4 및 이의 용도
KR101279145B1 (ko) * 2012-08-10 2013-06-26 주식회사 셀루메드 활성형 bmp7의 생산율 증가 방법
GB201412290D0 (en) 2014-07-10 2014-08-27 Cambridge Entpr Ltd Novel use

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003600A1 (en) * 1992-07-31 1994-02-17 Creative Biomolecules, Inc. Morphogenic protein soluble complex and composition thereof
WO1999003887A1 (en) * 1997-07-14 1999-01-28 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
WO1999037320A1 (en) * 1998-01-23 1999-07-29 Creative Biomolecules, Inc. Methods and compositions for enhancing cognitive function using morphogenic proteins
US20050114037A1 (en) * 2003-03-31 2005-05-26 Xencor, Inc. Methods for rational pegylation of proteins
WO2005097825A2 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
WO2007087053A2 (en) * 2005-12-22 2007-08-02 Centocor, Inc Bmp-7 variant compositions, methods and uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
IT1259042B (it) * 1992-01-27 1996-03-11 Mini Ricerca Scient Tecnolog Preparazione di vettori di espressione per la sintesi del polipeptide chiamato fattore osteogenetico op-1 in cellule eucariotiche di spodoptera frugiperda via infezione con baculovirus ricombinante
US6677432B1 (en) * 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003600A1 (en) * 1992-07-31 1994-02-17 Creative Biomolecules, Inc. Morphogenic protein soluble complex and composition thereof
WO1999003887A1 (en) * 1997-07-14 1999-01-28 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
WO1999037320A1 (en) * 1998-01-23 1999-07-29 Creative Biomolecules, Inc. Methods and compositions for enhancing cognitive function using morphogenic proteins
US20050114037A1 (en) * 2003-03-31 2005-05-26 Xencor, Inc. Methods for rational pegylation of proteins
WO2005097825A2 (en) * 2004-03-31 2005-10-20 Xencor, Inc. Bmp-7 variants with improved properties
WO2007087053A2 (en) * 2005-12-22 2007-08-02 Centocor, Inc Bmp-7 variant compositions, methods and uses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SWENCKI-UNDERWOOD ET AL: "Expression and characterization of a human BMP-7 variant with improved biochemical properties", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, vol. 57, no. 2, 21 December 2007 (2007-12-21), pages 312 - 319, XP022398606, ISSN: 1046-5928 *

Also Published As

Publication number Publication date
EP2056852A2 (de) 2009-05-13
WO2008014054A3 (en) 2009-04-09
JP2009544325A (ja) 2009-12-17
WO2008014054A2 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
IL230759A0 (en) Converted acyl anilide, the pharmaceutical composition containing it and its uses
GB0601143D0 (en) Uses, methods and compositions
GB0616111D0 (en) Agents, methods and uses
GB0706077D0 (en) Methods, Compositions and uses thereof
ZA200807714B (en) Gene disruptions, compositions and methods relating thereto
GB0607605D0 (en) Composition
GB0625586D0 (en) Composition
GB0819432D0 (en) Compound, composition and use
GB0623619D0 (en) Composition
EP2056852A4 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
GB0607562D0 (en) Method, composition and use
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
GB0625429D0 (en) Composition
GB0625430D0 (en) Composition
GB0712671D0 (en) Compounds, compositions and processes
GB0623618D0 (en) Composition
IL172976A0 (en) C.i. armwrestling
GB0720489D0 (en) Novel mixtures, compositions and ususe
GB0609701D0 (en) Composition
GB0614255D0 (en) Composition
GB0608658D0 (en) Composition
GB0602185D0 (en) Composition
GB0606493D0 (en) Composition
GB0602260D0 (en) Composition
GB0603408D0 (en) Composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/18 20060101ALI20090506BHEP

Ipc: A61K 38/16 20060101ALI20090506BHEP

Ipc: C07K 14/00 20060101ALI20090506BHEP

Ipc: C07K 14/51 20060101ALI20090506BHEP

Ipc: C07K 14/475 20060101ALI20090506BHEP

Ipc: C07K 14/46 20060101ALI20090506BHEP

Ipc: C07K 14/435 20060101ALI20090506BHEP

Ipc: C12N 15/63 20060101ALI20090506BHEP

Ipc: C12N 15/12 20060101ALI20090506BHEP

Ipc: C12N 15/00 20060101AFI20090506BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CENTOCOR ORTHO BIOTECH INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20091215

17Q First examination report despatched

Effective date: 20100409

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: JANSSEN BIOTECH, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121016